RESUMO
Advances in motor vehicle safety, trauma care, combat body armor, and cancer treatment have enhanced the life expectancy and functional expectations of patients with upper-extremity amputations. Upper-extremity surgeons have multiple surgical options to optimize the potential of emerging prosthetic technologies for this diverse patient group. Targeted muscle reinnervation is an evolving technique that improves control of myoelectric prostheses and can prevent or treat symptomatic neuromas. This review addresses current strategies for the care of patients with amputations proximal to the wrist with an emphasis on recent advancements in surgical techniques and prostheses.
Assuntos
Amputação Cirúrgica , Extremidade Superior/lesões , Extremidade Superior/cirurgia , Membros Artificiais , Tomada de Decisão Clínica , Eletromiografia , Retalhos de Tecido Biológico , Humanos , Músculo Esquelético/inervação , Neurorretroalimentação , Neuroma/etiologia , Neuroma/cirurgia , Osseointegração , Nervos Periféricos/transplante , Complicações Pós-Operatórias , Desenho de Prótese , Neoplasias de Tecidos Moles/etiologia , Neoplasias de Tecidos Moles/cirurgiaRESUMO
OBJECTIVES: To determine if cell saver (CS) use in patients with acetabular fractures reduces the volume or rate of allogeneic blood transfused intraoperatively and postoperatively and if this translated to a decrease in blood-related charges to the patient. DESIGN: Retrospective review. SETTING: Level 1 trauma center. PATIENTS: One hundred eighty-six patients with operatively treated acetabular fractures. INTERVENTION: All patients underwent open reduction internal fixation of their acetabular fracture. The decision to use CS was at the surgeon's discretion. MAIN OUTCOME MEASUREMENTS: The volume and rate of intraoperative and postoperative allogeneic blood transfused and blood-related charges were evaluated. RESULTS: CS was used in 60 cases (32%), and the average volume of blood autotransfused was 345 mL. No differences were observed in the rates (58.3% vs 48%, P = 0.1883) or the mean volumes (770 vs 518 mL, P = 0.0537) of intraoperative and postoperative allogeneic blood transfusions between the CS and the non-CS groups. Total blood-related charges in the CS group were significantly higher than that in the nonCS group ($1958 vs $694, P < 0.0001). Subanalyses based on fracture pattern, injury severity score, body mass index, days to surgery, and estimated blood loss were performed. In each subanalyses, no differences were observed in intraoperative and postoperative transfusion rates and volumes, and total blood-related charges were higher in the CS groups. CONCLUSIONS: In the routine use of CS in acetabular surgery, there was no reduction in the volume or rate of allogeneic blood transfused intraoperatively or postoperatively. However, blood-related charges were significantly increased.